Coronary Vessels, Procedure PCI
Conditions
Keywords
OCT, AI ,PCI
Brief summary
This study is to establish the primary hypothesis thatAI -QCA guided PCI is non-inferior to Optical coherence tomography-guided Percutaneous coronary intervention regarding minimal Stent area by Final OCT and Procedural MACE
Detailed description
1. AI-QCA-assisted DES implantation After coronary angiography, AI-QCA software will be used to determine the lesion length and the reference vessel diameter in real time to determine the appropriate stent size for implantation. The procedure is performed as follows: 1. Select the optimal projection angle providing the best view of the lesion. 2. Provide sufficient nitroglycerin for vasodilation. If the lesion is severely stenotic, perform balloon angioplasty, followed by nitroglycerin supply. 3. Perform AI-QCA to measure the length of the lesion and the inside diameter of the proximal and distal reference vessels. 4. Determine the stent length and size according to the AI-QCA measurements. Select a stent that is 20% larger than the distal reference vessel diameter and that can provide coverage for both the proximal and distal reference vessels. 5. Perform high-pressure balloon dilation after stent implantation, with the final balloon size being 20% larger than the distal and proximal reference vessel diameters. 6. Perform a final coronary angiogram if no procedural complications are observed on the angiogram and stent expansion is confirmed. 7. Perform a final OCT to measure the stent area (mm2), the primary efficacy endpoint. 8. If significant suboptimal stent results, such as severe underexpansion, extensive strut malapposition, or major stent edge dissection, occur, additional procedures to correct them are permitted to ensure patient safety, although they are generally discouraged. (The primary endpoint will be assessed by OCT run before such correction.) 2. OCT guided DES implantation After coronary angiography, OCT is performed to determine the appropriate stent size for implantation. After the stent procedure, OCT is performed again to check for an area that is smaller than the area of distal reference vessel and for sufficient dilatation. If necessary, high-pressure balloon dilation is performed to minimize residual stenosis. The procedure is performed as follows: 1. Select the optimal projection angle providing the best view of the lesion. 2. Provide sufficient nitroglycerin for vasodilation. If the lesion is severely stenotic, perform balloon angioplasty, followed by nitroglycerin supply. 3. Perform OCT to obtain pre-procedural images of the vessel. If there is a stenosis and OCT images cannot be obtained, perform OCT after adequate balloon angioplasty. 4. Determine the length and size of the stent to be implanted according to the OCT images. Select the stent size in consideration of the mean lumen diameter and mean external elastic lamina (EEL) diameter of the distal reference vessel. If the EEL is not observed, use a stent that is 0.25 mm larger than the mean lumen diameter. Select the length by measuring the length of the proximal and distal reference vessel segments on the OCT. 5. Perform high-pressure balloon dilation after stent implantation. Select the final balloon size by considering the inside diameters of the distal and proximal reference vessels and EEL diameter. 6. Perform OCT. If no procedure-related complications are observed and there is no underexpansion or malapposition of the stent, perform a final coronary angiogram. If procedure-related complications or underexpansion or malapposition of the stent is observed, correct it, and then perform a final OCT to measure the stent area (mm2), the primary efficacy endpoint.
Interventions
Percutaneous Coronary Intervention
Sponsors
Study design
Eligibility
Inclusion criteria
* Men or women at least 19 years of age * Patients with typical symptoms or objective evidence of myocardial ischemia and eligible for coronary angioplasty. * Subject with severe coronary artery disease undergoing PCI * Written informed consent
Exclusion criteria
* Angiographic
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Minimal Stent Area evaluated by OCT | 1hour | Minimal Stent Area evaluated by OCT after stenting of the target lesion |
| Procedural complications | 24hours | Procedural complications including angiographic dissection, perforation, or acute closure requiring active intervention after stent implantation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Angiographic endpoint | 24hours | Minimal lumen diameter at the stented segment, diameter stenosis at the stented segment, acute gain at the stented segment |
| Death | 6month | All-cause death , Cardiac and non-Cardiac death |
| MI | 6month | Any MI( periprocedural/spontaneous MI), Target vessel-MI and non-target vessel-MI |
| Stent thrombosis | 6month | definite/probable |
| Procedural success | 24hours | Stent expansion (≥ 90%) in final OCT assessment and successful stent delivery without target-lesion failure in 24 hours |
| Composite of event | 6month | Composite of all-cause death, myocardial infarction, stent thrombosis, or revascularization |
| Quality of life score assessed by the EQ-5D | 6month | The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. EQ-5D: the minimum and maximum values are 5 and 25 respectively. EQ VAS: the minimum and maximum values are 0 and 100 respectively. |
| Quality of life score assessed by Health-related Quality of Life Instrument with 8 Items (HINT-8) | 6month | HINT-8 was developed based on 4 health dimensions: physical, mental, social, and positive health dimensions. It consists of climbing stairs, endurance to pain, vitality, working, depression, memory, sleep, and happiness. |
| Cost-effective analysis | 6month | Cost-effective analysis based on average treatment costs for two treatment |
| Revascularization | 6month | Any revascularization,Target vessel and target lesion revascularization |
| OCT endpoint | 24hours | Stent expansion, stent malapposition, intra-stent tissue (plaque or thrombus) protrusion, untreated reference segment disease |
Countries
South Korea